Case 10 Flashcards
what is general anaesthesia?
a medically-induced coma and loss of protective reflexes resulting from the administration of one or more general anaesthetic agents
what are the purposes of general anaesthesia?
- analgesia - loss of response to pain
- amnesia - loss of memory
- immobility - loss of motor reflexes
- unconsciousness - loss of consciousness
- skeletal muscle relaxation
what is the theory of general anaesthetic action?
- anaesthetics alter neuron function by interacting directly with a small number of ion channels
- upon activation, channels change the electrical excitability of neurons by controlling the flow of depolarising (excitatory) or hyperpolarising (inhibitory) ions across the cell membrane via an ion channel that is integral with the receptor that senses the initial signal
- general anaesthetics primarily act by either enhancing inhibitory signals or by blocking excitatory signals
what happens during the pre-anaesthetic evaluation?
- key factors of this evaluation are the patient’s age; body mass index; medical and surgical history; current medications and fasting time
- also, evaluation of the patient’s airway, involving inspection of the mouth opening and visualisation of the soft tissues of the pharynx, is required
- if a tracheal tube is indicated and airway management is deemed difficult, then alternative methods of tracheal intubation may be required as part of the anaesthetic management
- consent must be obtained
what is the premedication? what does it include?
- this is preliminary medication which is administered on the ward - not everyone requires it
- this is medication that is administered prior to administration of a general anaesthetic
- anaesthetic premedication consists of a drug or combination of drugs that serve to complement or otherwise improve the quality of the anaesthetic
Premedication includes:
benzodiazepines
-diazepam, midazolam, temazepam, lorzepam
-anxiolysis, amnesia, sedation
opioids
- morphine - anxiolysis, analgesia, sedation, euphoria, nausea
anticholinergics
-antivagal, antisialagogue (reduce production of saliva), antiemetic (reduce vomiting), amnesic
antibiotic
-surgical implant, endocarditis
antacids
-reflux, hiatus hernia, pregnancy
What has to be monitored when under general anaesthetic?
- ECG - also help identify early signs of heart ischaemia
- blood pressure - invasive or non-invasive
- oxygen saturation - pulse oximetry - allows early detection of a fall in a patient’s haemoglobin saturation with oxygen (hypoxaemia)
- end tidal CO2 - carbon dioxide measurement (capnography)
- inspired oxygen - low oxygen alarm
- inspired agent concentration
- neuromuscular blockade
- airway pressures and flows
- temperature - to discern hypothermia or fever
- depth of anaesthesia
what are the stages of anaesthesia?
- induction
- there is an ‘excitement stage’ that occurs after induction and before maintenance - this is marked by excited and delirious activity - there may be an irregular heart rate and breathing rate
- maintenance
- reversal
Describe the induction stage
- intravenous vs. inhalation induction
- how they work, when they used
Anaesthetic agents may be administered by various routes, including inhalation, injection (intravenous, intramuscular or subcutaneous), oral, and rectal
Intravenous induction:
- bolus of drug injected
- travels to the brain
- highly lipid soluble
- rapidly enters the brain
- onset is in one arm-brain time (less than one minute)
- initial recovery by redistribution
- ultimate recovery by elimination
Once in the circulatory system, they are transported to their biochemical sites of action in the central and autonomic nervous system, where they exert their pharmacologic effects
Inhalation induction:
- vapour breathed in via lungs
- enters the blood
- travels to the brain
- highly lipid soluble
- enters the brain
- initial recovery by exhalation
- ultimate recovery by exhalation
- minimal amounts are metabolised
- onset of anaesthesia is faster with intravenous injection than with inhalation, taking about 10-20 seconds to induce total unconsciousness
- this has the advantage of avoiding the excitatory phase of anaesthesia, and thus reduces the complications related to induction of anaesthesia
- commonly used intravenous induction agents include propofol, sodium thiopentone, etomidate and ketamine
- an inhalational induction may be chosen where intravenous access is difficult to obtain, where difficulty maintaining the airway is anticipated, or due to patient preference
Describe the maintenance phase
- duration of action of IV induction agents
- how is maintenance achieved
- what else is given
- what happens at the end of surgery
- the duration of action of intravenous induction agents is in general 5-10 minutes, after which time spontaneous recovery of consciousness will occur
- in order to prolong anaesthesia for the required duration, anaesthesia must be ‘maintained’
This is achieved by allowing the patient to breathe a carefully controlled mixture of:
- oxygen - nitrous oxide - volatile anaesthetic agent (isoflurane) - this can also be achieved by having a carefully controlled continuous infusion propofol through an intravenous catheter
- inhaled agents (e.g. isoflurane, sevoflurane, desflurane) are frequently supplemented by intravenous anaesthetics, such as opioids (usually fentanyl or morphine) and sedative-hypnotics (usually propofol)
- at the end of surgery, the volatile or intravenous anaesthetic is discontinued
- recovery of consciousness occurs when the concentration of anaesthetic in the brain drops below a certain level (usually within 1 to 30 minutes, depending upon the duration of surgery)
what is muscle relaxation during surgery? what does it allow?
- ‘paralysis’ or temporary muscle relaxation with a neuromuscular blocker is an integral part of modern anaesthesia
- muscle relaxation allows surgery within major body cavities, e.g. abdomen and thorax, without the need for very deep anaesthesia, and is also used to facilitate endotracheal intubation
how do muscle relaxants work? what are examples of muscle relaxants?
- acetylcholine, the natural neurotransmitter substance at the neuromuscular junction, causes muscles to contract when it is released from nerve endings
- muscle relaxants work by preventing acetylcholine from attaching to its receptor
- e.g. atracurium, succinycholine (suxamethonium), tubocurarine (curare), rocuronium, vecuronium
what does paralysis of muscles of respiration, i.e. the diaphragm and intercostal muscles, and muscles of larynx require?
- requires that some form of artificial respiration be implemented
- the airways usually needs to be protected by means of an endotracheal tube due to paralysed larynx muscles
how are the effects of muscle relaxants reversed?
anticholinesterase drugs
what does general anaesthesia cause the loss of?
- protective airway reflexes (such as coughing)
- airway patency
- regular pattern due to the effect of anaesthetics, opioids, or muscle relaxants
what is done to maintain an open airway and regulate breathing within acceptable parameters?
- some form of ‘breathing tube’ is inserted in the airway after the patient is unconscious
- to enable mechanical ventilation, an endotracheal tube is often used (intubation)
describe the reversal stage
- this stops what is keeping the patient asleep
- reverse any muscle relaxants (neostigmine & glycopyrrolate)
- give the patient time to recover
what are the consequences of anaesthesia?
- affects respiration, cardiovascular system, CNS, renal system, gastrointestinal tract and liver
respiratory:
- spontaneous respiration
- normal negative pressure breathing
- supine position and V/Q matching
- respiratory depression - increase in CO2 - hypercapnia
- hypoxic on room air
- positive pressure ventilation
- inspiration is now positive pressure
- expiration is passive
- needs a tracheal tube
- increased incidence of chest infection (e.g. ventilator acquired pneumonia)
Cardiovascular:
- decreased venous return
- decreased cardiac output
- decreased force of contraction
- increase in arrhythmia potential
- vasodilation
- change in regional flow patterns
CNS (central venous system):
- unconsciousness
- depression of cerebral metabolism
- dreaming
- awareness
- specific EEG (electroencephalogram) changes
- possible long-term effects
what might be the consequence of agents with high lipid solubility?
they accumulate gradually in body fat and may produce a prolonged ‘hangover’ if used for a long operation
- this is because of the low blood flow to adipose tissue, meaning it can take many hours for the drug to enter and leave the fat
what does postoperative recovery include?
taking care of the unconscious patient:
- airway management, monitoring, position, pressure points, nerve damage, lifting and handling
Monitory and assessing the following is extremely important:
- oxygenation
- pain control
- fluid balance
- postoperative nausea and vomiting (PONV)
- cardiovascular stability
- conscious level
- urine output
what is postoperative management?
- early management - ‘recovery’
- late management:
- wound infection
- deep vein thrombosis (DVT)
- chest infection
- surgical problems
what is the safety of anaesthesia?
- mortality and morbidity are principally related to the type of surgery
- mortality and morbidity are also related to the type of surgery
- risk due to anaesthesia alone < 1 in 500,000
- anaesthesia may contribute to some deaths
What are the uses of anaesthetics in combination with other drugs? (summary of drugs used)
What does this combination allow?
- an intravenous anaesthetic for rapid induction (propofol)
- an inhalation anaesthetic to maintain anaesthetic during surgery (isoflurane)
- a perioperative opioid analgesic (fentanyl)
- a neuromuscular blocking agent to produce adequate muscle relaxation (atracurium)
- other muscle relaxation agents (suxamethonium)
- a muscarinic antagonist to prevent or treat bradycardia or to reduce bronchial and salivary secretions (atropine, glycopyrrolate)
- towards the end of the procedure, an anticholinesterase agent (neostigmine) to reverse the neuromuscular blockade and an analgesic for postoperative pain relief (opioid/NSAID)
Such combinations of drugs result in much faster induction and recovery, avoiding long (hazardous) periods of semi-consciousness, and it enables surgery to be carried out with less undesirable cardiorespiratory depression
what are the different sites that anaesthetic agents act on?
- GABA-A receptors
- two-pore domain k+ channels
- NMDA receptors
- glycine, nicotinic and 5-HT receptors
what are GABA-A receptors?
how do anaesthetics act on them?
GABA-A receptors are ligand-gated ion channels (ionotropic receptors)
- they are chlorine channels
- they are the most abundant fast inhibitory neurotransmitter receptors in the CNS
Almost all anaesthetics potentiate the action of GABA at the GABA-A receptor
- they have a positive modulation of the inhibitory function by causing an increased reflux of Cl- ions into the postsynaptic neurone
- anaesthetics mainly work on extrasynaptic GABA-A receptors
what are two-pore domain K+ channels? what anaesthetics are they affected by? and how?
- also known as ‘leak channels’
- inhalation inducing agents directly activate these channels, causing hyperpolarisation, thus reducing membrane excitability
- this may contribute to the analgesic, hypnotic and immobilising effects of these agents
- these channels are not affected by intravenous inducing agents
what are the effects of anaesthetics on the nervous system?
- enhance tonic inhibition (through enhancing the actions of GABA)
- reduce excitation (opening K+ channels - hyperpolarisation)
- inhibit excitatory synaptic transmission (by depressing transmitter release and inhibiting ligand-gated ion channels)
what brain regions are most sensitive to the effects of anaesthetics? what does inhibition of these regions result in?
- most sensitive appear to be the midbrain reticular formation, thalamic sensory relay nuclei and, to a lesser extent, parts of the cortex
- inhibition of these regions results in unconsciousness and analgesia
where does some anaesthetics cause inhibition?
particularly volatile ones, cause inhibition at the spinal level, producing a loss of reflex responses to painful stimuli
what happens as anaesthetic concentration is increased?
- all brain functions are progressively affected
- at high enough doses, all anaesthetics cause death by loss of cardiovascular reflexes and respiratory paralysis
what are inhalation anaesthetics?
- they are all small, lipid-soluble molecules that readily cross alveolar membranes
what determines the overall kinetic behaviour of an inhalation anaesthetic?
the rates of delivery of drug to and from the lungs, via (respectively) the inspired air and bloodstream
how can the main factors that determined the speed of induction and recovery be summarised?
Properties of the anaesthetic:
- blood:gas partition coefficient (solubility in blood) - speed of induction/recovery
- oil:gas partition coefficient (solubility in fat) - potency
Physiological factors:
- alveolar ventilation rate
- cardiac output
how is anaesthetic potency expressed?
as the minimal alveolar concentration (MAC)
- it is the concentration of vapour in the lungs that is needed to prevent movement (motor response) in 50% patients in response to surgical (pain-incision) stimulus
the potency of drug increases with what?
with increasing lipid solubility (the higher the lipid solubility is the lower the MAC)
Propofol
- what is it?
- onset and distribution rates?
- recovery rate?
- volume of distribution?
- mechanism of action?
- what are the side effects?
- an intravenous anaesthetic agent used for induction of general anaesthesia, after which anaesthesia may be maintained using a combination of medications
- it has a rapid onset of action (30s) and a rapid rate of distribution
- it is very rapidly metabolised to inactive metabolites - therefore giving rapid recovery with a small hangover effect
- 60L/kg (healthy adults)
- positive modulation of inhibitory function of GABA through GABA-A receptor
- less frequent side effects than other intravenous anaesthetic agents
- major side effects:
- hypotension and bradycardia
- respiratory depression
- pain with injection
- involuntary movement and adrenocortical suppression
- nausea and vomiting
- can also be given as a continuous infusion to maintain surgical anaesthesia without the need for any inhalation agent
isoflurane
- what is it?
- what is it always administered with?
- what is its mechanism of action?
- side effects?
- the most widely used volatile anaesthetic - inhalation inducing agent - used for maintenance of general anaesthesia
- always administered with air/pure oxygen and nitric oxide
mechanism of action:
- remains incompletely understood
- likely binds to GABA, glutamates (NMDA) and glycine receptors, but has different effects on each receptor
- relatively free from side effects
- major side effects:
- hypotension
- coronary vasodilator - exacerbate cardiac ischaemia in patient with coronary disease
- respiratory suppression
fentanyl
- what is it?
- onset and duration?
- dose?
- mechanism of action?
- a potent necrotic analgesic
- similar actions to morphine but with a more rapid onset and shorter duration of action
- 0.05 mg/mL intravenous
mechanism of action:
- strong agonist at the u-opioid receptor
- upon binding, it inhibits adenylate cyclase which causes an inhibition in the release of nociceptive substances such as substance P, GABA, dopamine etc.
neuromuscular-blocking drugs
- when used?
- how work?
- depolarising or non-depolarising?
- clinically, neuromuscular block is used only as an adjunct to anaesthesia, when artificial ventilation is available; it is not a therapeutic intervention
- the drugs work postsynaptically, either:
- blocking ACh receptors
- activating ACh receptors and thus causing persistent depolarisation - apart from suxamethonium, all of the drugs used clinically are non-depolarising agents
Non-depolarising neuromuscular blocking agents
- mechanism of action
- pharmacokinetics - excretion
- effects of agents
- side effects
Mechanism of action:
- act as competitive antagonists at the ACh receptors of the motor endplate
- also block facilitatory presynaptic autoreceptors and thus inhibit the release of ACh during repetitive stimulation of the motor neurone
Pharmocokinetics:
- most are metabolised by the liver or excreted unchanged in the urine; exceptions being atracurium, which hydrolyses spontaneously in plasma
Effects:
- motor paralysis - help facilitate endotracheal intubation
Major side effects:
- hypotension
- bronchospasm - due to histamine release
- ganglion block
Atracurium
- what is it?
- duration of action?
- optimum conditions?
- elimination?
- non-depolarising neuromuscular blocking agent - muscle relaxant
- short duration of action
- clinical advantage because of the decreased cardiovascular effects and decreased dependency on good kidney function
- optimum conditions - low pH (acidosis) and high temperature
- elimination is reduced due to respiratory acidosis
Suxamethonium
- what is it?
- duration of action?
- mechanism of action?
- rate of recovery?
- side effects?
- depolarising neuromuscular blocking agent - muscle relaxant
- duration of action lasts between 3-5 minutes
mechanism of action:
- ‘persistent’ depolarisation of neuromuscular junction
- caused by mimicking the effect of ACh but without being rapidly hydrolysed by acetylcholinesterase
- the constant depolarisation leads to desensitisation
- suxamethonium is hydrolysed by plasma cholinesterase (butyrycholinesterase (BuChE))
- rapid recovery that follows its withdrawal
Major side effects:
- bradycardia and hyperkalaemia
- increased intraocular pressure
- postoperative pain
Cholinesterase inhibiting drugs
- main forms of cholinesterase?
- where do inhibitors affect?
- clinical uses?
- side effects?
- acetylcholinesterase (AChE)
- mainly membrane-bound
- relatively specific for acetylcholine
- responsible for rapid acetylcholine hydrolysis at cholinergic synapses - butyrylcholinesterase (BuChE)
- relatively non-selective
- occurs in plasma and many tissues
- cholinesterase inhibitors affect peripheral as well as central cholinergic synapses
Cinical uses of anticholinesterase drugs:
- to reverse the action of non-depolarising neuromuscular blocking drugs at the end of an operation (neostigmine)
- atropine/glycopyrrolate must be given to limit parasympathomimetic effects - to treat myasthenia gravis (neostigmine)
Autonomic side effects:
- bradycardia
- hypotension
- bronchoconstriction
Muscular side effects:
- muscle fasciculation
- twitch tension
- depolarisation block
neostigmine
- what does it do?
- mechanism of action?
- acts to reverse effects of muscle relaxants
Mechanism of action:
- blocks acetylcholinesterase
- increases ACh in the neuromuscular junction (both nicotinic and muscarinic receptors)
- increases muscular contraction
Atropine and glycopyrrolate
- what are they?
- difference?
- what used for?
- these antagonise the muscarinic receptor and thus inhibit cholinergic transmission
- atropine can cross the blood-brain-barrier, whereas glycopyrrolate cannot
- they are used to limit parasympathomimetic effects caused by neostigmine
- it prevents neostigmine’s muscarinic effects such as bradycardia
Mannitol
- what is it?
- what used for?
- mechanism of action?
- osmotic diuretic
- inert in humans but it occurs naturally
- drug used to treat raised intracranial pressure (e.g. cerebral oedema)
Mechanism of action:
- these are pharmacologically inert substances that are filtered in the glomerulus but not reabsorbed by the nephron
- they cause diuresis because they increase the solute content of the fluid in the proximal tubule and collecting tubules
- this draws fluid from the body into the proximal tubule, thus decreasing the volume of fluid inside the body
- the result of this is that less water is reabsorbed and also less sodium
- this leads to a decrease in extracellular fluid volume
- also, they increase the plasma osmolality
- this increases the flow of water from tissues (brain and CSF included) into the interstitial fluid and plasma
- this reduces the intracranial pressure
what is sleep?
a state of physiological reversible unconsciousness
what causes the changes between sleep and wakefulness? where are there changes?
- the change from sleep to wakefulness is mediated by the reticular activating mechanism
- the change from wakefulness to sleep is also an active process affected by an arousal inhibitory mechanism based on a partial blockade of the thalamus and upper brainstem
- the cognitive change between sleep and wakefulness is accompanied by changes in the autonomic system, the cerebral blood flow and cerebral metabolism